FIGURE 7.
Schematic diagram shows scutellarin increases the sensitivity of non-small cell lung cancer to cisplatin via ERK/p53 and c-met/AKT signaling pathways.
Schematic diagram shows scutellarin increases the sensitivity of non-small cell lung cancer to cisplatin via ERK/p53 and c-met/AKT signaling pathways.